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To optimize appropriate antimicrobial use in a universi-
ty hospital and identify barriers hampering implementation
strategies, physicians were interviewed regarding their
opinions on antimicrobial policies. Results indicated that
effective strategies should include regular updates of
guidelines that incorporate the views of relevant depart-
ments and focus on addressing senior staff and residents
because residents do not make independent decisions in a
teaching-hospital setting. 
I
n an era of increasing bacterial resistance and the avail-
ability of a plethora of antimicrobial agents, hospitals
have developed policies to promote prudent antimicrobial
prescribing (1). The mainstay of such policies is preferably
an evidence-based antimicrobial treatment guideline (2).
Adherence to such hospital guidelines is often low to mod-
erate (40%–60%) (3,4). Therefore, much effort is put into
programs aimed at optimizing the antimicrobial prescrib-
ing practices of physicians. To plan an effective interven-
tion strategy, however, one must know the extent to which
clinicians perceive the need for a guideline and support
implementing that specific guideline (5). The impact of
different implementation strategies varies and when, and
under what conditions, a particular strategy should be used
is often not clear (1,3,4).
We examined barriers that existed in different groups of
physicians to the use of a general, hospitalwide antimicro-
bial treatment guideline. Aqualitative approach was chosen
to maximize the identification of relevant issues, especially
on content and development process of the guideline and
physicians’and organizational characteristics(6,7).
The Study
Physicians were asked on their opinions on antimicro-
bial policies in general and on aspects of the current antimi-
crobial treatment guideline and its usefulness in daily clin-
ical practice, by using in-depth interviews lasting 20–45
minutes. That antimicrobial treatment guideline was drawn
up by the hospitals’ antibiotic use committee, which was
composed of specialists of relevant departments. Paper
copies of the antimicrobial treatment guideline were dis-
tributed hospitalwide, in 1995, with an update in 1999.
From the Department of Internal Medicine of the
University Hospital, Groningen, physicians were recruited
through their chief medical officers in October and
November 2001. Interviewees were not paid; all involved
were informed that interview data would be strictly confi-
dential to guarantee interviewees independence. One resi-
dent and one supervisor were interviewed from each of six
internal medicine subspecialties—intensive care, general
internal medicine, pulmonology, gastroenterology, nephrol-
ogy, and hematology. Residents had 1–6 years of precertifi-
cation training, and supervisors had been board-certified
for 1 to 23 years as a specialist. From the group of infec-
tious disease consultants, two clinical microbiologists and a
consulting infectious disease specialist were interviewed.
Each interview was concluded with a case-scenario to
explore agreement between general opinions on antimicro-
bial use and response to a specific infectious disease case.
Interviews were audiotaped and transcribed verbatim;
the content was analyzed by P.M. and W.R. One recording
of an interview with a clinical microbiologist was damaged
and could not be used. Recurrent topics were attributed to
dominant themes. Important issues and themes emerging
from previous interviews were incorporated into subse-
quent interviews. Themes were classified as barriers relat-
ed to 1) the guideline, 2) physicians’characteristics, and 3)
characteristics of the institution. Interviewing and analysis
were partly simultaneous, which is consistent with the
grounded theory approach (8). Physicians were inter-
viewed once. After 15 physicians had been interviewed, no
new issues came up, and we stopped interviewing. 
Barriers Related to the Guideline 
All physicians but one were aware of the guideline,
although six never had received a personal copy (Table 1).
They suggested that more effort should be put into famil-
iarizing physicians with the guideline. Residents preferred
an electronically available copy of the guideline. All physi-
cians agreed with the basic principle of the guideline: an
initially empirical antimicrobial treatment should be
streamlined to the most narrow-spectrum antimicrobial
agent effective against isolated pathogens. Physicians
stressed that the guideline needed to be consistent with
existing policies, concise, and up-to-date. Supervisors’
expected their own prescribing to be consistent with the
guideline, without actually knowing its contents, though
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†University Hospital Groningen, Groningen, the Netherlands residents experienced the opposite: residents experienced
that supervisors regularly prescribed or advised them to
prescribe antibiotics that were not recommended by the
hospital guideline. Infectious disease consultants, as mem-
bers of the antibiotic use committee, had contradictory
views on one aspect of the contents of the guideline. They
supported its recommendations for using aminoglycosides
when appropriate but were reluctant to advise prescribing
them for individual patients. 
Barriers Related to Physicians’ Characteristics 
Residents were more receptive to using the guideline
than were supervisors, especially for rare infectious dis-
eases because they lack experience and have to look up the
most effective therapy for a specific condition more often.
Junior residents acknowledged a lack of knowledge in
interpreting culture and antimicrobial sensitivity test
results, resulting in problems with effectively using the
guideline based on such tests (Table 1). Infectious disease
consultants shared this concern. In contrast to their state-
ments supporting streamlining antimicrobial therapy, resi-
dents reported that they were not inclined to change therapy
with an effective broad-spectrum antimicrobial agent, once
the pathogens’sensitivity test results became available. 
Supervisors did not perceive a strengthened antibiotic
policy as an advantage because they considered guidelines
a threat to their professional autonomy and as interfering
with daily clinical practice. Prescribing an antimicrobial
agent was often considered a routine activity. Supervisors
doubted the need for an antimicrobial use policy, which
was reinforced by the fact that they did not perceive many
problems with antimicrobial resistance in daily clinical
practice. 
At the time of the interviews, a paper critical-pathway1
was discussed as a possible decision support tool for
improved antimicrobial therapy. Supervisors and residents
were negative towards such a tool. Supervisors considered
it an unnecessary and unacceptable infringement of daily
clinical work, while residents were mostly concerned
about the added paperwork. The infectious disease con-
sultants had great trust in a critical-pathway to guide
antimicrobial drug prescribing, welcoming its educational
value and potential for improving actual prescribing
behavior.  
Social and Institutional Context 
Residents in most teaching hospitals are not independ-
ent decision makers, and experienced specialists supervise
their prescribing choices (Table 1). Residents run the day-
to-day clinical care of patients in our hospital; they rotate
to different departments at 4-month intervals and have to
adapt each time to the mores of a new department or super-
visor. They considered the antimicrobial-treatment
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1A paper "critical-pathway" combines an antimicrobial drug order
form with a decision support tool. Filling out a few relevant case-
characteristics guides the prescriber to the guideline's recommen-
dation for that specific case. 
Table 1. Quotations illustrating themes 
Level of  Quotation 
Guideline characteristics  “It would be great to have an electronic version” or “…even better everyone | would have| a handheld PDA with 
guideline.” [R1]
a 
“You have to go with the flow and not necessarily against it…otherwise you will have a hard time |getting the 
guideline accepted|.
b” [S1] 
Physicians’ characteristics  “I often look in the booklet |guideline| especially for those indications that you do not encounter much…” [R4] 
“…you sometimes get these incomplete results: just a gram-stain without sensitivity results, I then rather wait 
for the complete results” [R5] 
“…they |residents| do not look at the quality of the |culture and sensitivity| tests” [ID] 
“I would continue. |with broad-spectrum therapy even when a cultured pathogen is sensitive to a more narrow 
spectrum agent| The patient is doing well, he is responding to his antibiotic therapy. I would not streamline at 
this time. I do not see any reason. ...Never change a winning team.” [R1] 
“My autonomy… as a lung specialist I feel I have and can decide on |what treatment for| pulmonary infections” 
[S2] 
“…for the large majority of patients it |choice of antibiotic| is just very clear, it is just a formality.” [S3] 
“In our department? I cannot remember the time we had resistant pneumococci. We know they exist and we 
remind each other of that, but we have never had that here.” [S2] 
horrible...I can imagine obliging people to use it |registration form| in the framework of their training… but to 
have to defend this as a standard measure, I do think this goes too far.” [S5] 
“A wonderful idea… it could be quite a guiding instrument ... it should be education and intervention.” [ID] 
Social and institutional context  “…and when you move to another department you learn within a week their |supervising specialists| prescribing 
preferences… they will just keep an eye on you.” [R4] 
“I would first consult my supervisor and if he gets stuck I would ring up a microbiologist.” [R5] 
aR, resident; S, supervisor; ID, infectious disease specialist. 
b|Text| is added by the author for clarification. This additional text is merely meant to clarify a physician’s statement, and we have made every effort to not alter the 
implication of any statement. 
 guideline a helpful tool in coping with existing differences
between departments; some departments had their own
protocols but mostly discussed antimicrobial use policies
informally in departmental patient reviews. The role of the
infectious disease consultant was one of adviser. Residents
would primarily seek advice from their supervisor, and the
final decision is always made by the supervisor. 
Case Scenario
To further ascertain the physicians’ use of the antibiot-
ic treatment guideline, we presented a scenario for a case
of community-acquired pneumonia (Appendix). All physi-
cians, except for one supervisor, began the patient’s treat-
ment with broad-spectrum antimicrobial agents. Residents
were hesitant to streamline initial therapy, fearing that such
changed therapy might be clinically less effective.
Infectious disease consultants and supervisors streamlined
therapy based on gram-stain results only.
Conclusion
Our findings support earlier study findings that an
intensive implementation strategy is needed for physi-
cians to make their prescribing practices consistent with
guideline recommendations. Table 2 shows the identified
barriers along with our suggestions about which interven-
tions might be effective. Any implementation process
passes through different stages, each requiring a different
intervention approach (9). The supervisors are in an early
stage of such a process; they need to be motivated to use
the antimicrobial-treatment guideline and to change their
prescribing behavior accordingly. Clear involvement in
the development of the antimicrobial-treatment guideline
may overcome reservations of supervisors with regard to
feelings of losing their autonomy. Supervisors see no need
to follow the guideline recommendations; they do not per-
ceive antimicrobial resistance as a problem, which may be
understandable in view of the low resistance patterns in
Dutch hospitals (10). Their routine decision-making
leaves little room for guideline consultations. Providing
feedback on their own and departmental prescribing pat-
terns may identify areas to be improved and raise aware-
ness of a need to change (11,12). The usefulness of the
guidelines could be emphasized for nonroutine cases,
about which physicians were less reluctant to consult the
guideline.
Residents are more open to using the guidelines; they
are willing to adopt the recommendations because it helps
them in their learning process, making them ideal candi-
dates for interventions. For them, the barrier to be
addressed is whether streamlining is safe. One way of
affirming this is facilitating a better understanding of cul-
ture and sensitivity tests, for example, through infectious
disease consultants’ support (6). As paper critical-path-
ways will not suffice, face-to-face educational visits, so-
called academic detailing, may be a better way to improve
residents’ prescribing practices (13). Academic detailing
should focus not only on interpretation of test results but
also on acting on the implications. Infectious disease con-
sultants should be motivated to give advice consistent with
the guideline.
In an institutional context where residents are not inde-
pendent decision makers, any implementation plan should
combine strategies aimed at both residents and supervi-
sors. For residents who change departments regularly, a
generally adopted hospitalwide guideline facilitates a con-
sistent learning environment and increase their rational
decision making. Addressing the role model function of
supervisors for residents may be one more way to motivate
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Table 2. Barriers and proposed interventions 
  Barriers identified  Proposed interventions 
Guideline  1.  Dissemination 
 
2.  Credibility of content 
1.  Develop and actively distribute hard-copy and electronic version 
2.  Incorporate departmental policies, and update regularly 
– For both 1 and 2, organize meetings to introduce guidelines   and 
set up an active outreach committee 
Readiness to change or use the guideline 
Supervising specialists 
3.  No need for a guideline, because 
– Routine prescribing 
– No perceived resistance problems 
4.  Autonomy 
 
 
3.  A combination of group and individual feedback (“academic 
detailing”) to supervisors and residents 
 
4.  Incorporate specialists/departmental views in guideline (see 2, above) 
Residents 
5.  Insufficient knowledge 
– Of culture results 
– Low self-efficacy regarding streamlining 
 
5.  Active educational support on interpretation of culture-results and 
for streamlining therapy 
Physician 
 
Infectious disease consultants 
6.  Overestimate the feasibility of an intervention 
 
6.  Check support before implementation of an intervention 
Social and 
institutional 
context 
7.  Residents are not independent decision makers and 
their prescribing decisions are supervised by specialists 
8.  Infectious disease consultant secondary to supervisor 
9.  Different guidelines between departments 
7.  Target both residents and supervising specialists 
 
8.  Target supervisor, formalize advice of consultants 
9.  Incorporate departmental policies (see 2 and 5, above) them to use the guideline, in view of the impact that super-
visors have on residents (14).
The limited number of physicians interviewed in this
study is in line with a qualitative research approach aimed
at generating hypotheses (15). We found physicians to be
very open in expressing their sometimes negative views
during the interview sessions. Residents were quite frank
about their relationship with their supervisors, possibly
because the interviewer had no direct link to any chief
medical officer and confidentiality was assured.
In conclusion, intervention strategies should focus on
improving dissemination and credibility of the recommen-
dations, focusing on both supervisors and residents,
although each group needs a tailored approach. Active out-
reach, as in face-to-face educational visits, may be the best
approach to tackling the various barriers in one interven-
tion program aimed at optimizing antimicrobial use.
This study was part of a larger intervention study sponsored
by an unconditional grant from the board of the University
Hospital Groningen and the Health Care Insurance Board, the
Netherlands.
Dr. Mol is a junior researcher at the Department of Clinical
Pharmacology at the University of Groningen, with a research
interest in antimicrobial use in hospitals. He has worked in a
community-pharmacy in the Netherlands and as a regional phar-
macist in Namibia.
Appendix: Case Scenario
The following scenario was presented for a case of communi-
ty-acquired pneumonia.
A male patient aged 63 years, with hypertension treated with
metoprolol and hydrochlorothiazide, is referred by a local gener-
al practitioner to the emergency department of your hospital at
11:30 p.m. He has a temperature of 40°C and is dyspneic but not
confused. Physical examination reveals only crackles and
egophony in the right lower lung field. 
Question (Q) 1. What additional examinations would you
request?
Q2. What kind of therapy would you suggest?
The next morning a chest x-ray shows infiltration in the right
lower lung field, and the sputum culture shows gram-positive
diplococci. 
Q3. Does this influence your therapeutic decision?
Two days later the patient is improving and the fever has sub-
sided. Blood-culture results read literally as follows:
Streptococcus pneumoniae, sensitive to penicillin G, amoxicillin,
amoxicillin with clavulanic acid, and cefuroxime.
Q4. Do you adapt your therapeutic choice?
Hospital Guideline on 
Community-Acquired Pneumonia
For this straightforward case of a patient with a clearly com-
munity-acquired pneumonia, the initial empiric treatment accord-
ing to the hospital guideline would be amoxicillin/clavulanic acid
or cefuroxime. The guideline recommends streamlining anti-
microbial therapy to intravenous penicillin G or oral amoxicillin
based on sensitivity tests of the isolated S. pneumoniae.
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